XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenues        
Premiums $ 9,803 $ 9,012 $ 19,774 $ 18,011
Net investment income 340 352 686 681
Total revenues 38,819 11,480 76,765 22,893
Benefits and Expenses        
Medical costs and other benefit expenses 7,576 6,845 15,196 13,617
Pharmacy and other service costs 24,963 613 49,013 1,174
Selling, general and administrative expenses 3,380 2,837 6,683 5,582
Amortization of other acquired intangible assets 737 24 1,480 51
Total benefits and expenses 36,656 10,319 72,372 20,424
Income from operations 2,163 1,161 4,393 2,469
Interest expense and other (428) (56) (880) (113)
Net realized investment gains (losses) 23 (3) 33 (36)
Income (loss) before income taxes 1,758 1,102 3,546 2,320
Total income taxes 348 294 764 595
Net Income 1,410 808 2,782 1,725
Less: net income (loss) attributable to noncontrolling interests 2 2 6 4
Shareholders' net income $ 1,408 $ 806 $ 2,776 $ 1,721
Shareholders' net income per share:        
Basic $ 3.73 $ 3.32 $ 7.33 $ 7.10
Diluted $ 3.70 $ 3.29 $ 7.26 $ 7.01
Fees and other revenues [Member]        
Revenues        
Pharmacy revenues, fees and other revenues $ 2,388 $ 1,358 $ 4,838 $ 2,726
Pharmacy revenues [Member]        
Revenues        
Pharmacy revenues, fees and other revenues $ 26,288 $ 758 $ 51,467 $ 1,475